Abstract
In this review we describe in detail the available technologies used for investigating the substrate specificity of proteases. Critical comparison of the available detection methods and their choice for certain type of screening is discussed. We present successful strategies along with appropriate examples for the design and synthesis of combinatorial libraries of substrates using both chemical and biological approaches. Proteomic tools for the identification of natural substrates of proteases are also discussed.
Keywords: Protease, substrate, library, fluorogenic, substrate specificity, combinatorial, positional scanning substrate combinatorial library, MEROPS, Activity Based Probes, ABPs, AMC, 7-amino-4-methylcoumarin, AFC, 7-amino-4-trifluoromethylcoumarin, ACC, 7-amino-4-carbamoylmethylcoumarin, 6-amino-1-naphtalenesulfonamide, ANSN, substrate activity screening, SAS, N-acyl-7-amino-4-methylcoumarin acetic acid, AMCA, p-nitroanilide, pNA, 5-fluorosalicylic acid, fsa, Tb(EDTA), rhodesain, Trypanasoma brucei, quencher, Leishmania mexicana, stromelysin, matrilysin, collagenase-3, MMP-2, MT1-MMP, furin, thrombin, granzyme B, PROTOMAP, iTRAQ, iCat, PICS, Proteomic Identification of protease Cleavage Sites, serine proteases, aspartic proteases, cysteine proteases
Current Medicinal Chemistry
Title: Current Strategies for Probing Substrate Specificity of Proteases
Volume: 17 Issue: 33
Author(s): M. Poreba and M. Drag
Affiliation:
Keywords: Protease, substrate, library, fluorogenic, substrate specificity, combinatorial, positional scanning substrate combinatorial library, MEROPS, Activity Based Probes, ABPs, AMC, 7-amino-4-methylcoumarin, AFC, 7-amino-4-trifluoromethylcoumarin, ACC, 7-amino-4-carbamoylmethylcoumarin, 6-amino-1-naphtalenesulfonamide, ANSN, substrate activity screening, SAS, N-acyl-7-amino-4-methylcoumarin acetic acid, AMCA, p-nitroanilide, pNA, 5-fluorosalicylic acid, fsa, Tb(EDTA), rhodesain, Trypanasoma brucei, quencher, Leishmania mexicana, stromelysin, matrilysin, collagenase-3, MMP-2, MT1-MMP, furin, thrombin, granzyme B, PROTOMAP, iTRAQ, iCat, PICS, Proteomic Identification of protease Cleavage Sites, serine proteases, aspartic proteases, cysteine proteases
Abstract: In this review we describe in detail the available technologies used for investigating the substrate specificity of proteases. Critical comparison of the available detection methods and their choice for certain type of screening is discussed. We present successful strategies along with appropriate examples for the design and synthesis of combinatorial libraries of substrates using both chemical and biological approaches. Proteomic tools for the identification of natural substrates of proteases are also discussed.
Export Options
About this article
Cite this article as:
Poreba M. and Drag M., Current Strategies for Probing Substrate Specificity of Proteases, Current Medicinal Chemistry 2010; 17 (33) . https://dx.doi.org/10.2174/092986710793205381
DOI https://dx.doi.org/10.2174/092986710793205381 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Oxidative Stress in Tumor Angiogenesis - Therapeutic Targets
Current Pharmaceutical Design Oxidative Stress and Cancer: The Role of Nrf2
Current Cancer Drug Targets Reposition of the Fungicide Ciclopirox for Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Epidemiological Profile of Naive HIV-1/AIDS Patients in Istanbul: The Largest Case Series from Turkey
Current HIV Research Kinase Inhibitors Targeting Anti-angiogenesis as Anti-cancer Therapies
Current Angiogenesis (Discontinued) Radiopharmaceuticals in Tumor Hypoxia Imaging: A Review Focused on Medicinal Chemistry Aspects
Anti-Cancer Agents in Medicinal Chemistry Gemcitabine: A Critical Nucleoside for Cancer Therapy
Current Medicinal Chemistry Anabolic Factors in Degenerative Joint Disease
Current Drug Targets Signal Transduction Pathways and Transcriptional Mechanisms as Targets for Prevention of Emergence of Multidrug Resistance in Human Cancer Cells
Current Drug Targets ETS Proteins and MMPs: Partners in Invasion and Metastasis
Current Drug Targets Role of Secondary Alcohol Metabolites in Anthracycline Cardiotoxicity: from Hypotheses to New Drugs
Drug Design Reviews - Online (Discontinued) Viral Based Gene Therapy for Prostate Cancer
Current Gene Therapy HIF-1α and Calcium Signaling as Targets for Treatment of Prostate Cancer by Cardiac Glycosides
Current Cancer Drug Targets Substance Abuse, HIV-1 and Hepatitis
Current HIV Research Inhibition of Cellular Proliferation by Drug Targeting of Cyclin-Dependent Kinases
Current Pharmaceutical Biotechnology Dendritic Cells and their Receptors in Antitumor Immune Response
Current Molecular Medicine Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
Current Medicinal Chemistry Novel Insights Into c-Src
Current Pharmaceutical Design Recent Patents Therapeutic Agents for Cancer
Recent Patents on Anti-Cancer Drug Discovery Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases
Current Cancer Drug Targets